Invasive Aspergillosis Withdrawn Phase 4 Trials for Micafungin (DB01141)

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00423163A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisTreatment